Atlas Trials

Eltrombopag for Moderate Aplastic Anemia

Clinical trial NCT01328587 · COMPLETED

Trial details

NCT number
NCT01328587
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate Aplastic AnemiaUnilineage Bone Marrow Failure Disorders
Start date
2012-03-13
Primary completion
2018-03-30
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.